(Q41231716)

28 September 2017

Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

28 September 2017

0 references

1 reference

1 reference

Moayyedi P

1

1 reference

28 September 2017

Congleton J

2

1 reference

28 September 2017

Page RL

3

1 reference

28 September 2017

Pearson SB

4

1 reference

28 September 2017

Muers MF

5

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

28 September 2017

1 reference

28 September 2017

50

1 reference

28 September 2017

8

1 reference

28 September 2017

834-837

1 reference

VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Ipratropium bromide in acute asthma.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Anticholinergic, Antimuscarinic Bronchodilators1,2

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Combination therapy--a review of clinical studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

A measure of quality of life for clinical trials in chronic lung disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Response to nebulized ipratropium bromide and terbutaline in acute severe asthma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

A long-term prospective assessment of home nebulizer treatment

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Salbutamol and ipratropium in partially reversible airway obstruction

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=474895

Role of the parasympathetic system in airway obstruction due to emphysema

19 August 2018

1 reference

12 December 2020

A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease

1 reference

12 December 2020

Comparison of a fenoterol/ipratropium combination with salbutamol from metered dose inhalers in subjects with chronic partially reversible airways obstruction

1 reference

12 December 2020

Predicting Response to Bronchodilator Therapy in Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction

1 reference

12 December 2020

Accuracy of pulmonary function tests in predicting exercise tolerance in chronic obstructive pulmonary disease

1 reference

12 December 2020

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

12 December 2020

A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence

1 reference

12 December 2020

Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy

1 reference

12 December 2020

Comparison of ipratropium bromide and salbutamol by aerosolized solution

1 reference

12 December 2020

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

12 December 2020

Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.50.8.834

1 reference

28 September 2017

1 reference

28 September 2017

PubMed publication ID

7570433

1 reference